Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

SMS Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SMSPHARMA | BSE: 532815

₹355.55

up-down-arrow ₹-6.90 (-1.90%)

As on 28-Aug-2026IST

Market cap

info icon

₹3,328 Cr

Revenue (TTM)

info icon

₹898 Cr

P/E Ratio

info icon

32.5

P/B Ratio

info icon

4.1

Div. Yield

info icon

0.1 %

Edit peer-selector-edit
SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Market cap (₹ Cr)
 3,328 32,104 29,892 29,103 26,871
Revenue (₹ Cr)
 898 3,564 1,936 9,205 1,462
Net Profit (₹ Cr)
 89.48 414.00 288.22 -371.81 387.35
Net Margin (%)
 9.86 11.23 14.79 -3.93 26.01
RoE (%)
 13.52 8.38 29.77 -3.85 25.18
Price to Earnings
 32.50 78.49 103.71 -- 69.57
Price-To-Book
 4.13 6.38 22.27 3.64 15.55

Income Statement (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Operating Revenue arrow
897.79 3,564.00 1,935.80 9,205.28 1,461.80
Total Income arrow
907.29 3,686.00 1,948.58 9,449.59 1,489.25
Total Expenditure arrow
724.93 2,792.00 1,485.56 8,195.15 919.25
EBITDA arrow
172.86 772.00 450.24 1,010.13 542.56
Depreciation arrow
40.16 226.00 50.83 857.51 37.68
EBIT arrow
132.70 546.00 399.41 152.62 504.88
Interest arrow
22.74 217.00 40.84 342.73 3.77
Other Income arrow
9.50 122.00 12.78 244.31 27.45
Exceptional Items arrow
0.00 12.00 0.00 -216.88 0.00
Profit before Tax arrow
119.47 463.00 371.35 -162.68 528.56
Provision for Tax arrow
29.99 49.00 83.14 209.13 141.21
Profit after Tax arrow
89.48 414.00 288.22 -371.81 387.35

Liabilities (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Shareholder's Funds arrow
785.81 4,940.00 1,288.82 8,162.62 1,653.56
Minority Interest arrow
0.00 -5.00 0.00 0.00 -1.13
Non-Current Liabilities arrow
223.65 1,712.00 202.03 5,044.14 42.40
Current Liabilities arrow
352.98 1,622.00 835.87 4,758.28 230.82
Total Liabilities arrow
1,172.81 8,100.00 1,451.43 15,513.53 1,549.26

Assets (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Non-Current Assets arrow
681.94 5,343.00 519.60 10,211.52 1,026.85
Current Assets arrow
638.01 2,606.00 1,681.81 7,191.66 881.27
Total Assets arrow
1,172.81 8,100.00 1,451.43 15,513.53 1,549.26
Total Debt* arrow
310.76 1,859.00 393.17 4,720.27 8.18
Net Current Assets arrow
285.04 984.00 845.94 2,433.38 650.46
Contingent Liabilities arrow
11.00 770.26 12.25 99.76 15.38

Cashflow (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Cash From Operating Activities arrow
81.71 -22.00 159.18 892.30 118.34
Cash Flow from Investing Activities arrow
-123.43 -783.00 -64.81 -477.46 -223.94
Cash from Financing Activities arrow
47.08 409.00 -39.81 -440.83 261.12
Net Cash Inflow / Outflow arrow
5.36 -396.00 54.56 -25.99 155.52

Ratios

Profitability Ratios

 SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
ROCE (%) arrow
12.55 4.07 26.97 6.61 20.14
ROE (%) arrow
13.52 8.38 29.77 -3.85 25.18
ROA (%) arrow
7.12 4.94 24.77 -2.21 21.93
EBIT Margin (%) arrow
14.78 15.32 20.63 1.66 34.54
Net Margin (%) arrow
9.86 11.23 14.79 -3.93 26.01
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Revenue Growth (%) arrow
10.25 18.37 46.65 0.78 40.90
EBIT Growth (%) arrow
21.59 252.26 62.13 -70.53 124.50
Net Profit Growth (%) arrow
28.31 377.85 89.49 -1,383.43 104.15
EPS Growth (%) arrow
29.81 1,001.33 78.60 -484.84 42.32
Book Value Growth (%) arrow
22.85 29.77 42.49 2.28 94.96

Valuation Ratios

 SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Price / Earnings arrow
32.50 80.56 102.12 -93.01 69.57
Price / Book Value arrow
4.13 6.38 22.27 3.64 15.55
Dividend Yield (%) arrow
0.11 0.00 0.08 0.00 0.08
EV/EBITDA arrow
20.81 43.48 66.20 32.91 49.08
Market Cap (₹ Cr) arrow
1,885.64 23,064.69 0.00 29,731.27 19,988.69

Solvency Ratios

 SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debt to Equity arrow
0.22 0.31 0.11 0.53 0.01
Short term debt to equity ratio arrow
0.20 0.11 0.54 0.12 0.02
Current Ratio arrow
1.81 1.61 2.01 1.51 3.82
Quick Ratio arrow
0.81 1.06 1.14 0.87 2.82
Interest Coverage arrow
6.25 3.13 10.09 0.53 141.16

Operating Efficiency Ratios

 SMS Pharma Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debtors to sales (%) arrow
24.04 16.50 26.28 23.44 24.80
Asset Turnover arrow
0.71 0.43 1.66 0.55 0.83
Receivable days arrow
94.73 60.36 47.59 77.05 90.06
Inventory Days arrow
111.76 64.42 62.58 77.13 61.02
Payable days arrow
110.75 218.94 228.78 173.49 96.06
Cash Conversion Cycle arrow
95.74 -94.15 -118.62 -19.30 55.02
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...